Correlation Between NYSE Composite and Algos Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Algos Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Algos Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Algos Pharmaceutical Corp, you can compare the effects of market volatilities on NYSE Composite and Algos Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Algos Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Algos Pharmaceutical.
Diversification Opportunities for NYSE Composite and Algos Pharmaceutical
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NYSE and Algos is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Algos Pharmaceutical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Algos Pharmaceutical Corp and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Algos Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Algos Pharmaceutical Corp has no effect on the direction of NYSE Composite i.e., NYSE Composite and Algos Pharmaceutical go up and down completely randomly.
Pair Corralation between NYSE Composite and Algos Pharmaceutical
If you would invest 1,985,329 in NYSE Composite on September 13, 2024 and sell it today you would earn a total of 3,774 from holding NYSE Composite or generate 0.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
NYSE Composite vs. Algos Pharmaceutical Corp
Performance |
| Timeline |
NYSE Composite and Algos Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Algos Pharmaceutical Corp
Pair trading matchups for Algos Pharmaceutical
Pair Trading with NYSE Composite and Algos Pharmaceutical
The main advantage of trading using opposite NYSE Composite and Algos Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Algos Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Algos Pharmaceutical will offset losses from the drop in Algos Pharmaceutical's long position.| NYSE Composite vs. Boston Beer | NYSE Composite vs. Freedom Bank of | NYSE Composite vs. KeyCorp | NYSE Composite vs. LithiumBank Resources Corp |
| Algos Pharmaceutical vs. Mid Atlantic Home Health | Algos Pharmaceutical vs. United Homes Group | Algos Pharmaceutical vs. Forsys Metals Corp | Algos Pharmaceutical vs. Enersys |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |